LIVING DOLL
agency: Digitas Health
brand: Arimidex
client: AstraZeneca
photo from left: Rita DiStefano Schuerman, account director • Mike Wilson, director, design technology • Andrew le Blanc, associate creative director • Ilana Grossman, VP, director of marketing
Surviving breast cancer is cause for celebration. And on behalf of the adjuvant breast cancer therapy Arimidex, Digitas Health found a way to let users celebrate life and courage by creating a place online where breast cancer survivors can gather and connect. CelebrationChain.com is the first—and still the only—branded social media site for pharma, says the agency.
Visitors to CelebrationChain.com can create a digital paper doll and send it to a friend to celebrate her life and courage in the face of breast cancer. Different clothing and hairstyle options allow users to customize the doll. All told, it's a poignant way for AstraZeneca to sponsor communication among the close-knit community of breast cancer patients and their advocates.
"AstraZeneca was really forward thinking in challenging us to come up with this," says Ilana Grossman. "All the design elements were grounded in the experience of the customer. These women, they're fighters. They celebrate life. They celebrate their survivorship." In sponsoring this site, Andrew le Blanc described the client as "brave" and "caring," adding, "Here's a company making an investment for a community."
That investment wasn't just emotional, but financial as well. For every doll created, AstraZeneca donates $1 to the nonprofit group Living Beyond Breast Cancer. Since the site's launch in October (Breast Cancer Month), more than 5,500 women have visited the site; they've made over 7,500 virtual dolls for friends and loved ones.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.